Health Products

ADVIA CHEMISTRY OPIATE ASSAYS

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
290
Manufacturer
Siemens Healthcare Diagnostics Inc.
511 Benedict Ave
Tarrytown
10591
New York
UNITED STATES
B. ADVIA 1200 CHEMISTRY SYSTEM- OPIATE (OP_2) ASSAY210378763
290
Manufacturer
Siemens Healthcare Diagnostics Inc.
511 Benedict Ave
Tarrytown
10591
New York
UNITED STATES
A. ADVIA CHEMISTRY OPIATE (OP_2) ASSAY10378763

Introduction

Affected Products
  1. ADVIA CHEMISTRY OPIATE (OP_2) ASSAY
  2. ADVIA 1200 CHEMISTRY SYSTEM- OPIATE (OP_2) ASSAY2

Reason

Siemens investigation confirmed that the introduction of a new SYVA polyclonal antibody lot (G1) for use in the dimension urine opiates screen has resulted in an alteration of specificity for Levallorphan, Levorphanol, Nalorphine and Oxycodone at the 300 and 2000 NG/ml cutoff concentration. As a result in the change in sensitivity to the cross reactant, the claims for these compounds are no longer accurate for either the 300 or 2000 NG/ml cutoff as stated within the instructions for use (IFU). Further investigation confirmed that SYVA, Beckman Coulter and Advia Chemistry Opiate reagents are impacted as well due to a common raw material used in the assays.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime